Houston, Texas, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Publicly-held Megola, Inc. (OTC Pink: MGON) is pleased to announce current status of revenues and future direction of sales distributions into the United States and Canadian CBD (Cannabidiol) markets. Acordy President Francisco Baez states: “For 2018, the Company is rapidly approaching 2 million euros ($2.4 million US Dollars) in revenues. This reflects an increase of over 300% compared with the same nine month period of 2017. Pretax profits for the nine months ending 9-30-2018 came in at €490,524 (approximately USD$ 585,000) representing nearly a 200 % increase over 2017. With Megola introducing CBD products and CBD infused olive oil into the U.S. and Canada, we are poised for substantial growth in 2019”. Eric Ottens, CEO of Megola states, “Utilizing our existing products from our olive farms and olive oil production facilities coupled with CBD and marijuana legalization, we are in perfect position to quickly launch, products and distribute into the US and Canadian cannabis markets.”
Francisco Baez also stated, “Our legal counsel is continuing to take the necessary steps to bring Megola, Inc. current with all OTC filings and we plan on moving up to OTCQB or OTCQX within the next 6-12 months..”
The company also wishes to notify all shareholders and persons of interest that Megola, Inc. will be making announcements and updates via social media media. Updates can be found at on newly created new social media channels on Twitter https://twitter.com/MegolaMMJand a Facebook Business Page https://www.facebook.com/Megola-Inc-1844493719004617 .
Management also wants to notify all shareholders and persons of interest to visit http://www.acordyinvest.com for updates and notifications of the company’s original programs and directives.
About Acordy SA.
Acordy S.A. is currently a privately owned Spanish company that was formed in 2014. Acordy has been primarily involved in the production and distribution of food items from Spain with a concentration in olive oils and wines from the Iberian Peninsula. Acordy is also involved with commercial horse breeding. The company is currently planning to become involved in the production and distribution of medical marijuana products and already has the necessary infrastructure in place to commence commercializing CBD products in the next three months.
###
Sections of this press release contain forward looking statements that reflect management’s best judgement based on factors currently known but involve significant risks and uncertainties. Actual results could differ materially from those anticipated in these forward looking statements as a result of a number of factors that will be included in the forthcoming financial statements. Forward looking information provided pursuant to the safe harbor established by recent securities legislation should be evaluated in the context of these factors.
SOURCE Megola, Inc.
RELATED LINKS
http://www.acordyinvest.com
https://www.facebook.com/Megola-Inc-1844493719004617
https://twitter.com/MegolaMMJ
For further information, contact:
Eric Ottens
weottens@gmail.com